Abstract
A linearized, replicating, shuttle vector plasmid, pZ189, was used to measure in vivo DNA joining ability of cells from patients with the cancer-prone, immunodeficient, chromosome breakage disorder, Bloom's syndrome (BS). The BS cell lines we studied were reported to contain reduced in vitro activity of DNA ligase I. We assessed in vivo joining ability by transfecting linear plasmids with overlapping or blunt ends (produced by EcoRI or StuI) into BS and normal fibroblast or lymphoblast host cells and measuring the amount of re-joined, replicated plasmids by their ability to transform bacteria. With plasmids having either overlapping or blunt ends we found a 1.3- to 3-fold lower (P less than 0.05) joining efficiency in BS cells than in the normal cells. The mutation frequency of the recovered plasmids was measured by screening for function of the suppressor tRNA contained in pZ189, for plasmid size, for presence of restriction sites, or by DNA sequencing. The spontaneous mutation frequency with the circular plasmid was 0.05-0.08% with both BS cell lines, values 2- to 21-fold higher (P less than 0.03) than with the normal cell lines. The mutation frequency with the linear plasmid passaged through both BS cell lines was 21-52%, values 1.4- to 5.4-fold higher (P less than 0.001) than with the normal lines. Detailed analysis of 210 recovered plasmids revealed an increase (P less than or equal to 0.001) in deletions, insertions or complex mutations at the joining sites, and in point mutations with the EcoRI cut plasmid with the BS cells in comparison to the normal cells.(ABSTRACT TRUNCATED AT 250 WORDS)
MeSH Terms
Bloom Syndrome/genetics,metabolism
DNA/genetics
DNA Damage
DNA Ligases/deficiency
Humans
Mutation
Plasmids
Transfection
Chemicals
DNA
DNA Ligases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rünger T M
Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, MD 20892.
Kraemer K H
References (25)
25 references, click to expand
-
Abnormal immune responses of Bloom's syndrome lymphocytes in vitro.
J Clin Invest. 1975 Jul;56(1):1-7
PMID: 124745
-
Multiple point mutations in a shuttle vector propagated in human cells: evidence for an error-prone DNA polymerase activity.
Proc Natl Acad Sci U S A. 1987 Jul;84(14):4944-8
PMID: 3474635
-
Abnormal ultraviolet mutagenic spectrum in plasmid DNA replicated in cultured fibroblasts from a patient with the skin cancer-prone disease, xeroderma pigmentosum.
J Clin Invest. 1987 Dec;80(6):1613-7
PMID: 3680516
-
Structural alterations of DNA ligase I in Bloom syndrome.
Proc Natl Acad Sci U S A. 1987 Nov;84(22):8016-20
PMID: 3479778
-
Developmental stage specificity of the lymphoid V(D)J recombination activity.
Genes Dev. 1987 Oct;1(8):751-61
PMID: 3428598
-
Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome.
Proc Natl Acad Sci U S A. 1989 Jan;86(2):670-4
PMID: 2911598
-
DNA ligases of eukaryotes.
FEBS Lett. 1976 Aug 1;67(1):1-8
PMID: 782919
-
Immune responses in four patients with Bloom syndrome.
Clin Immunol Immunopathol. 1979 Jan;12(1):12-9
PMID: 421370
-
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res. 1979 Nov 24;7(6):1513-23
PMID: 388356
-
Recombination in SV40-infected cells: viral DNA sequences at sites of circularization of transfecting linear DNA.
Virology. 1981 Mar;109(2):353-65
PMID: 6259817
-
Elevated spontaneous mutation rate in Bloom syndrome fibroblasts.
Proc Natl Acad Sci U S A. 1981 May;78(5):3133-7
PMID: 6942420
-
Impaired B-cell differentiation and T-cell regulatory function in four patients with Bloom's syndrome.
Clin Immunol Immunopathol. 1982 Feb;22(2):247-58
PMID: 6980748
-
Somatic cells efficiently join unrelated DNA segments end-to-end.
Mol Cell Biol. 1982 Oct;2(10):1258-69
PMID: 6294502
-
High mutation frequency in DNA transfected into mammalian cells.
Proc Natl Acad Sci U S A. 1983 May;80(10):3015-9
PMID: 6574469
-
Bloom's syndrome: evidence for an increased mutation frequency in vivo.
Science. 1983 Aug 26;221(4613):851-3
PMID: 6879180
-
Bloom's syndrome XI. Progress report for 1983.
Clin Genet. 1984 Feb;25(2):166-74
PMID: 6705251
-
How damaged is the biologically active subpopulation of transfected DNA?
Mol Cell Biol. 1984 Mar;4(3):387-98
PMID: 6325874
-
Mutagenesis of a shuttle vector plasmid in mammalian cells.
Mol Cell Biol. 1984 Mar;4(3):435-41
PMID: 6325877
-
One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells.
Proc Natl Acad Sci U S A. 1985 Oct;82(19):6622-6
PMID: 2995975
-
A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells.
Gene. 1985;38(1-3):233-7
PMID: 2998945
-
Impaired natural killer cell activity in Bloom's syndrome could be restored by human recombinant IL-2 in vitro.
Clin Immunol Immunopathol. 1985 May;35(2):226-33
PMID: 3878246
-
Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells.
Proc Natl Acad Sci U S A. 1986 Nov;83(21):8273-7
PMID: 3464953
-
Effects of Bloom's syndrome fibroblasts on genetic recombination and mutagenesis of herpes simplex virus type 1.
Somat Cell Mol Genet. 1987 Mar;13(2):111-7
PMID: 3031825
-
Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals.
Cell. 1987 Jun 19;49(6):775-83
PMID: 3495343
-
Bloom's syndrome.
J Am Acad Dermatol. 1987 Sep;17(3):479-88
PMID: 3655026